Jode Goodridge
Impact in
- Oncology top 10%
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Oncology 20
- CAR-T cell therapy research 20
- Immunology 11
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Co-authors
- Bahram Valamehr (20 shared papers)Tom Lee (17 shared papers)Ryan Bjordahl (16 shared papers)Sajid Mahmood (9 shared papers)Brian Groff (13 shared papers)Karl‐Johan Malmberg (8 shared papers)Greg Bonello (8 shared papers)Svetlana Gaidarova (7 shared papers)
- Journals
- Blood (11 papers)Cancer Research (6 papers)Cell stem cell (1 paper)The Lancet (1 paper)Regular and Young Investigator Award Abstracts (1 paper)
- Partner nations
- United StatesNorwayGermany
In The Last Decade
Jode Goodridge
20 papers receiving 314 citations
Jode Goodridge's Hit Papers
Peers
Comparison fields: 5 of 24
- Oncology 245
- Immunology 195
- Hematology 28
- Genetics 42
- Molecular Biology 81
Countries citing papers authored by Jode Goodridge
This map shows the geographic impact of Jode Goodridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jode Goodridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jode Goodridge more than expected).
Fields of papers citing papers by Jode Goodridge
This network shows the impact of papers produced by Jode Goodridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jode Goodridge. The network helps show where Jode Goodridge may publish in the future.
Co-authors
The 25 scholars most cited alongside Jode Goodridge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 67 | |
| 2 | Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial Hit paper breakdown → | 2025 | 66 |
| 3 | 2022 | 44 | |
| 4 | 2020 | 35 | |
| 5 | 2019 | 26 | |
| 6 | 2024 | 23 | |
| 7 | 2022 | 18 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2022 | 2 | |
| 15 | 2020 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2022 | 1 |
About Jode Goodridge
Jode Goodridge is a scholar working on Oncology, Immunology, Molecular Biology, Hematology and Organic Chemistry, having authored 20 papers that have together received 322 indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Immune Cell Function and Interaction (10 papers), CRISPR and Genetic Engineering (4 papers), RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (3 papers), Multiple Myeloma Research and Treatments (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Oncology (245 citations), Immunology (195 citations), Hematology (28 citations), Genetics (42 citations) and Molecular Biology (81 citations). Jode Goodridge has collaborated with scholars based in United States, Norway and Germany. Frequent co-authors include Bahram Valamehr, Tom Lee, Ryan Bjordahl, Sajid Mahmood, Brian Groff, Karl‐Johan Malmberg, Greg Bonello, Svetlana Gaidarova, Lilly Wong and Robert Blum. Their work appears in journals such as Blood, Cancer Research, Cell stem cell, The Lancet and Regular and Young Investigator Award Abstracts.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.